期刊
NANO LETTERS
卷 8, 期 12, 页码 4116-4121出版社
AMER CHEMICAL SOC
DOI: 10.1021/nl802098g
关键词
-
类别
资金
- National Aeronautics and Space Administration (NASA) [NAG8-1675]
- Ben Franklin Technology Partnership of the Commonwealth of Pennsylvania Center of Excellence in NanoParticulates
- National Science Foundation [DGE-0338240]
- National Institutes of Health [HL-074311]
- Keystone Nano, Inc
Paradigm-shifting modalities to more efficiently deliver drugs to cancerous lesions require the following attributes: nanoscale-size, targetability, and stability under physiological conditions. Often, these nanoscale drug delivery vehicles are limited due to agglomeration, poor solubility, or cytotoxicity. Thus, we have designed a methodology to encapsulate hydrophobic antineoplastic chemotherapeutics within a 20-30 nm diameter, pH-responsive, nonagglomerating, nontoxic calcium phosphate nanoparticle matrix. In the present study, we report on calcium phosphate nanocomposite particles (CPNPs) that encapsulate both fluorophores and chemotherapeutics, are colloidally stable in physiological solution for an extended time at 37 degrees C and can efficaciously deliver hydrophobic antineoplastic agents, such as ceramide, in several cell model systems.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据